$3M Verdict Awarded Against GSK For Failing To Warn Of Suicide In Generic Paxil Case
CHICAGO — An Illinois federal jury on April 20 awarded $3 million to a widow after finding that GlaxoSmithKline PLC (GSK) failed to update the label for the antidepressant Paxil to...To view the full article, register now.
Already a subscriber? Click here to view full article